Resources

3 Resources for

biotechnology and eli lilly

  • Subscribe to this listing via:
  • RSS
  • Email
Alkermes shares pop on FDA's diabetes-drug response
Alkermes Inc. shares popped Monday on news that federal regulators responded positively to a new diabetes-drug application filed by the Waltham, Mass.-based biotechnology firm and its development partners, Amylin Pharmaceuticals Inc. and Eli Lilly and Co. Alkermes (Nasdaq: ALKS) disclosed in a regulatory filing Monday that the U.S. Food...
Tags: Nasdaq Stock Market Inc., FDA, Eli Lilly & Co.
News items 2010-03-15
Biotech company Acrux thrills market with licensing deal worth up to $US335 million
The RBA's upbeat assessment of our economy indicates rates have further to rise, although there are a few dark clouds way off in the distance.After a difficult 18 months for the Australian biotechnology sector, Melbourne-based drug developer Acrux has boosted the industry's confidence by signing a licensing deal worth up...
Tags: biotechnology, Licensing Deal Worth
News items 2010-03-16
Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
"Great leadership requires patience, decisiveness, intelligence, execution and compassion. David encompasses all of these qualities and much more. He is a tireless advocate for patient-centered policies here in the U.S. and abroad and has set the bar high for his peers," said PhRMA President and Chief Executive Officer Billy Tauzin....
Tags: Health Care
News items 2010-03-18
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement